Abstract
Several characteristics of current infectious diseases show that most patients of infectious disease are immune tolerant hosts. Most infection-induced microorganisms come from patients themselves and people around them with normal indigenous microflora. The effectiveness of antibiotics are weakened with the emergence of multidrug resistant strains. The model of ‘infection→antibiotics→reinfection→reuse of antibiotics’ must not be followed in order to more effectively fight against infection from various critical points such as outbreaks and spreads. Infectious microecology provides theoretical and practical support to avoid and control infections. The introduction of mechanisms and applications of probiotics in prevention and control of infectious diseases will be introduced and discussed below in details.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Backhed F, Ley R E, Sonnenburg J L, et al. Host-bacterial mutualism in the human intestine. Science, 2005, 307: 1915–1920.
Sullivan A, Edlund C, Nord C E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis, 2001, 1: 101.
Haghighi H R, Gong J, Gyles C L, et al. Modulation of antibody-mediated immune response by probiotics in chickens. Clin Diagn Lab Immunol, 2005, 12: 1387–1392.
Della R F, Criniti V, Della P V, et al. Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett, 2001, 499: 199–204.
Kelly D, Conway S. Bacterial modulation of mucosal innate immunity. Mol Immunol, 2005, 42: 895–901.
Donohur D C, Salminen S. Safety of probiotic lactic acid bacteria. Asia Pac J Clin Nutr, 1996, 5: 25–28.
Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Pasteur, 1994, 92: 45–67.
Reuter G. Present and future of probiotics in Germany and in central Europe. Bioscience Microflora, 1997, 16: 43–51.
Uncan S H, Louis P, Flint J H. Lactate-utilizing bacteria,isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol, 2004, 70: 5810–5817.
Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol, 2003, 30: 15–20.
Wu Z W, Li L J, Ma W H, et al. Study on the intestinal microbial colonization resistance in patients with chronic severe hepatitis. Chin J Hepatol, 2001, 9: 329–330.
Han D W. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol, 2002, 8: 961–965.
Floch M H. Irritable bowel syndrome,and inflammatory bowel disease. Curr Treat Options Gastroenterol, 2003, 6: 283–288.
Zhang Q P, Duan L F. Current progress in the study of subhealth. Journal of health care and medicine in Chinese PLA, 2003, 5: 67.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Zhejiang University Press, Hangzhou and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Yuan, J., Xie, A. (2014). Microecology Intervention in Prevention and Treatment of Infectious Diseases. In: Li, L. (eds) Infectious Microecology. Advanced Topics in Science and Technology in China. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43883-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-662-43883-1_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43882-4
Online ISBN: 978-3-662-43883-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)